A new study overturns the traditional view of where tau pathology begins by showing that tau is synthesized in dendrites, not just in axons or after relocation within the neuron.

Advanced imaging reveals tau proteins are produced specifically in dendrites, challenging the longstanding idea that mature tau detaches from axonal microtubules and then travels to dendrites and the cell body.

The study proposes a revised model: pathological tau may arise in dendrites if the local quality-control system fails, rather than solely from mislocalization of tau from axons.

The work was published in Nature Neuroscience, led by Kapil V. Ramachandran of Columbia University, using a technique called STARFISH to pinpoint where proteins are first produced inside neurons.

Neuroproteasomes sit near tau-producing ribosomes, suggesting neurons immediately inspect and dispose of misfolded or improperly folded tau as soon as it’s made to prevent aggregation under normal conditions.

About one-third of newly formed tau is rapidly destroyed within minutes by these neuroproteasomes near ribosomes, revealing an immediate dendritic quality-control mechanism regulating tau abundance.

Although not proving causation, the findings highlight a previously overlooked stage in tau biology—the initial synthesis and immediate quality control in dendrites—as a potential early intervention target to prevent tangle formation.

Implications: preserving dendritic quality-control mechanisms could open new avenues to halt tau pathology before neurofibrillary tangles develop.